Tag: ATEV NASDAQ
Humacyte Stock Drops 18% Due to FDA Delay for ATEV (NASDAQ:HUMA)
Humacyte, a biotechnology company listed on the NASDAQ under the ticker symbol HUMA, experienced a significant drop in its stock price of 18% in after-hours trading on Friday. This decline came as a result...